insights_auto
Outlook: 47.1% bullish·5.0% bearish
Go to analysischevron_right
LLY:NYSE
Eli Lilly And Co
$1,347.11
arrow_downward
-0.30%(-4.01) 1D
$1,348.83
arrow_upward
+0.13% (+1.72)bedtimeAfter hours
Closed: Nov 20, 4:02:49 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LLY...
Open
$1,362.38
High
$1,372.05
Low
$1,341.76
Mkt. cap
1.27T
Avg. vol.
2.85M
Volume
3.51M
Dividend
0.51%
Quarterly dividend
$1.73
Ex-dividend date
Nov 13, 2026
P/E ratio
43.73
52-wk high
$1,475.25
52-wk low
$850.51
EPS
$30.81
Beta
0.40
Shares outstanding
940.74M
No. of employees
50K
Open
$1,362.38
High
$1,372.05
Low
$1,341.76
Mkt. cap
1.27T
Avg. vol.
2.85M
Volume
3.51M
Dividend
0.51%
Quarterly dividend
$1.73
Ex-dividend date
Nov 13, 2026
P/E ratio
43.73
52-wk high
$1,475.25
52-wk low
$850.51
EPS
$30.81
Beta
0.40
Shares outstanding
940.74M
No. of employees
50K
News stories
From web sources and news partners
Yahoo Finance
·
2 hours ago
Eli Lilly (LLY) After ObesityWeek Is The Stock Still Undervalued
The Motley Fool
·
6 hours ago
AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy for 2027?
Zacks
·
6 hours ago
Lilly vs. Pfizer: Which Drugmaker Has Stronger Growth Prospects?
ad-hoc-news.de
·
7 hours ago
Eli Lilly and Co. stock: Health Canada clears Mounjaro use
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly And Co
CEODavid A. Ricks
Employees50K
Founded1876
HeadquartersIndianapolis, Indiana, United States
SectorHealth Care
IndustryPharmaceutical industry
Websitelilly.com